DFB Bioscience

DFB Bioscience is a privately held Texas-based healthcare holding company that operates as a hybrid between an operating company and a strategic investment firm. The company focuses on identifying, developing, and commercializing innovative therapies, particularly in the fields of oncology, dermatology, and wound care. DFB Bioscience is best known for its role in founding and managing several successful life science entities, including Healthpoint, DPT Laboratories, and more recently, Celsion and NanOlogy. Through its subsidiaries and partnerships, the company advances a diverse portfolio ranging from gene-mediated cytotoxic immunotherapies to specialized drug delivery systems for solid tumors.